Elborn, J. S., Ramsey, B. W., Boyle, M. P., Konstan, M. W., Huang, X., Marigowda, G., . . . Wainwright, C. E. (2016). Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup. Lancet Respir Med.
Citação norma ChicagoElborn, J. Stuart, Bonnie W. Ramsey, Michael P. Boyle, Michael W. Konstan, Xiaohong Huang, Gautham Marigowda, David Waltz, and Claire E. Wainwright. "Efficacy and Safety of Lumacaftor/ivacaftor Combination Therapy in Patients With Cystic Fibrosis Homozygous for Phe508del CFTR By Pulmonary Function Subgroup." Lancet Respir Med 2016.
MLA CitationElborn, J. Stuart, et al. "Efficacy and Safety of Lumacaftor/ivacaftor Combination Therapy in Patients With Cystic Fibrosis Homozygous for Phe508del CFTR By Pulmonary Function Subgroup." Lancet Respir Med 2016.